Showing 3521-3530 of 7238 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0709_04-php/22799/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0509_05-php/22827/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.You Want to Start A New Practice: Now What?
https://practicaldermatology.com/topics/general-topics/PD0309_12-php/22866/After making the decision to start a practice, constructing a solid business plan and financial overview is critical.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0309_06-php/22860/What Do New PhRMA Guidelines Mean for Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0309_04-php/22858/Revisions to the "Code on Interactions" are taking effect, but what do they really mean for the typical clinician?Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0209_05-php/22877/- And the ASDS Stegman Award Goes to … Susan H. Weinkle, MDhttps://practicaldermatology.com/news/and-the-asds-stegman-award-goes-to-susan-h-weinkle-md/2458017/Bradenton, FL-based dermatologist Susan H. Weinkle, MD received the Samuel J. St
- Tralokinumab Data for H&N AD Presented at EADVhttps://practicaldermatology.com/news/tralokinumab-data-hn-ad-presented-eadv/2468323/Nine-month interim data from the TRACE study, showing that tralokinumab/tralokinumab-ldrm reduced the severity of moderate-to-severe atopic dermatitis (AD) in the head and neck region of the body (H&N), were shared through one of LEO Pharma’s five late-breaking oral presentations at the 33rd